terfenadine has been researched along with Bronchiectasis in 1 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Bronchiectasis: Persistent abnormal dilatation of the bronchi.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a placebo-controlled trial, the effect was assessed of an histamine H1-receptor antagonist, terfenadine (60 mg twice daily) and an H2-receptor antagonist cimetidine (400 mg twice daily) on the sputum production, dyspnoea score and lung function of 12 adult patients with generalized bronchiectasis." | 5.05 | Effect of H1- and H2-receptor antagonists on sputum volume and lung function in patients with generalized bronchiectasis. ( Anderson, J; Eiser, NM; Mills, JG, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, J | 1 |
| Eiser, NM | 1 |
| Mills, JG | 1 |
1 trial available for terfenadine and Bronchiectasis
| Article | Year |
|---|---|
Effect of H1- and H2-receptor antagonists on sputum volume and lung function in patients with generalized bronchiectasis.
Topics: Adult; Aged; Benzhydryl Compounds; Bronchiectasis; Cimetidine; Clinical Trials as Topic; Double-Blin | 1985 |